Hongbing Shen

40.4k citations
558 papers · 18.4k · 4 hit papers · h-index 63

Impact in

  • Cancer Research top 0.05%
    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Circular RNAs in diseases
    • RNA modifications and cancer
    • DNA Repair Mechanisms
    • Epigenetics and DNA Methylation

Papers in

    • RNA modifications and cancer 96
    • Epigenetics and DNA Methylation 54
    • DNA Repair Mechanisms 41
    • Cancer-related molecular mechanisms research 80
    • MicroRNA in disease regulation 47

Hongbing Shen

539 papers receiving 18.1k citations

Hongbing Shen's Hit Papers

FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2 2022 · 152 citations
1520+6+12Years since publication250500750

Peers

Hongbing Shen
Comparison fields: 5 of 189
  • Cancer Research 6.5k
  • Molecular Biology 9.8k
  • Oncology 3.0k
  • Modeling and Simulation 418
  • Reproductive Medicine 626
Replace Zhibin Hu with:
Zhibin Hu China
Nikolaos G. Papadopoulos Greece
J. Jaime United States
Guangfu Jin China
Philip S. Rosenberg United States
Benny Zee Hong Kong
Richard Sylvester Belgium
Feng Chen China
Wei Zhang China
Christopher I. Amos United States
Hongbing Shen relative to Zhibin Hu China Zhibin Hu's profile →
Citations per field
00.5×1.5×
Zhibin Hu · 1×
Citations per year

Countries citing papers authored by Hongbing Shen

Since Specialization
Citations

This map shows the geographic impact of Hongbing Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongbing Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongbing Shen more than expected).

Fields of papers citing papers by Hongbing Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongbing Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongbing Shen. The network helps show where Hongbing Shen may publish in the future.

Co-authors

The 25 scholars most cited alongside Hongbing Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hongbing Shen Line = papers co-authored together Hongbing Shen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 558 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China
Hit paper breakdown →
2020884
2
Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer
Hit paper breakdown →
2010660
3
Genetic variants of miRNA sequences and non–small cell lung cancer survival
Hit paper breakdown →
2008512
4 2010373
5 2008330
6 2009255
7 2011240
8 2002234
9 2012233
10 2021213
11 2014191
12 2005189
13 2012181
14 2000173
15 2015173
16 2018172
17 2010163
18
FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2
Hit paper breakdown →
2022152
19 2012151
20
A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.
2002149

About Hongbing Shen

Hongbing Shen is a scholar working on Molecular Biology, Cancer Research, Genetics, Epidemiology and Oncology, having authored 558 papers that have together received 18.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (96 papers), Cancer-related molecular mechanisms research (80 papers), Epigenetics and DNA Methylation (54 papers), Genetic Associations and Epidemiology (49 papers), MicroRNA in disease regulation (47 papers), DNA Repair Mechanisms (41 papers), Genetic factors in colorectal cancer (38 papers) and Liver Disease Diagnosis and Treatment (26 papers). The work is most often cited by research in Cancer Research (6.5k citations), Molecular Biology (9.8k citations), Oncology (3.0k citations), Modeling and Simulation (418 citations) and Reproductive Medicine (626 citations). Hongbing Shen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhibin Hu, Guangfu Jin, Hongxia Ma, Qingyi Wei, Juncheng Dai, Jianming Wang, Tian Tian, Xinru Wang, Yijiang Chen and Margaret R. Spitz. Their work appears in journals such as International Journal of Cancer, PLoS ONE, Carcinogenesis, Molecular Carcinogenesis and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact